Cocrystal Pharma Inc. (COCP)
NASDAQ: COCP
· Real-Time Price · USD
1.21
-0.01 (-0.82%)
At close: Oct 03, 2025, 3:59 PM
1.23
1.65%
After-hours: Oct 03, 2025, 07:50 PM EDT
-0.82% (1D)
| Bid | 1.21 |
| Market Cap | 12.4M |
| Revenue (ttm) | 136K |
| Net Income (ttm) | -12.56M |
| EPS (ttm) | -1.25 |
| PE Ratio (ttm) | -0.97 |
| Forward PE | -1.42 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.23 |
| Volume | 132,877 |
| Avg. Volume (20D) | 1,518,685 |
| Open | 1.23 |
| Previous Close | 1.22 |
| Day's Range | 1.20 - 1.24 |
| 52-Week Range | 1.12 - 3.26 |
| Beta | 2.24 |
| Ex-Dividend Date | n/a |
About COCP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol COCP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for COCP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+9.72%
Cocrystal Pharma shares are trading higher after t...
Unlock content with
Pro Subscription
4 months ago
+9.09%
Cocrystal Pharma shares are trading higher after the company announced its CC-42344 virology study exhibited strong antiviral activity against the H5N1 avian influenza A strain.
